Mehta Analysis: What Can Tesla Teach Pharma?
Health Breakthroughs Demand Regulatory Revolution
Executive Summary
The transformation of the automotive world has many lessons for biopharma, especially on the regulatory front, believes Viren Mehta of Mehta Partners.